Pilot Implementation of Clinical Genomic Data into the Native Electronic Health Record: Challenges of Scalability

ACI open Pub Date : 2020-07-01 DOI:10.1055/s-0040-1721490
Nephi A. Walton, Darren K. Johnson, T. Person, Jonathon C. Reynolds, Marc S. Williams
{"title":"Pilot Implementation of Clinical Genomic Data into the Native Electronic Health Record: Challenges of Scalability","authors":"Nephi A. Walton, Darren K. Johnson, T. Person, Jonathon C. Reynolds, Marc S. Williams","doi":"10.1055/s-0040-1721490","DOIUrl":null,"url":null,"abstract":"Abstract Background Recently, electronic health record (EHR) vendors have allowed for the storage of discrete genomic data within the EHR. With this new capability there remain many challenges related to adoption and implementation. Geisinger has genomic data available for approximately 145,000 patients. With the goal of integrating genetic data into the EHR for the entire sequenced population, we performed a pilot study on a subpopulation to assess the plausibility of large-scale deployment. Objectives Import genetic results into the EHR for seven pharmacogenes, Center for Disease Control tier one conditions, and hereditary hemochromatosis. Build decision support and information resources for each condition. Identify barriers to scaling the deployment. Identify short-term and long-term solutions to overcome identified barriers. Methods Discrete genomic variants were imported into the EHR. Maintenance guidelines and information resources were developed for each genetic condition and best practice alerts were built for pharmacogenomic variants. Weekly calls were held to address barriers to implementation. A list of challenges was maintained throughout the process. Solutions were proposed and categorized into short-term and long-term solutions. Results Challenges were identified and solutions proposed for five discrete areas: Transmitting data from the laboratory to the EHR. Maintenance of information and decision support. Disparate implementation needs of geneticists versus primary care. Differing perceptions/uses of discrete genomic data versus a PDF report. Classification and reclassification of variants. Conclusion Scaling the use of genomic data in the EHR requires the engagement of hospitals, open standards communities, laboratories, EHR vendors, and genomic information resources.","PeriodicalId":72041,"journal":{"name":"ACI open","volume":"04 1","pages":"e162 - e166"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-0040-1721490","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACI open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0040-1721490","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Abstract Background Recently, electronic health record (EHR) vendors have allowed for the storage of discrete genomic data within the EHR. With this new capability there remain many challenges related to adoption and implementation. Geisinger has genomic data available for approximately 145,000 patients. With the goal of integrating genetic data into the EHR for the entire sequenced population, we performed a pilot study on a subpopulation to assess the plausibility of large-scale deployment. Objectives Import genetic results into the EHR for seven pharmacogenes, Center for Disease Control tier one conditions, and hereditary hemochromatosis. Build decision support and information resources for each condition. Identify barriers to scaling the deployment. Identify short-term and long-term solutions to overcome identified barriers. Methods Discrete genomic variants were imported into the EHR. Maintenance guidelines and information resources were developed for each genetic condition and best practice alerts were built for pharmacogenomic variants. Weekly calls were held to address barriers to implementation. A list of challenges was maintained throughout the process. Solutions were proposed and categorized into short-term and long-term solutions. Results Challenges were identified and solutions proposed for five discrete areas: Transmitting data from the laboratory to the EHR. Maintenance of information and decision support. Disparate implementation needs of geneticists versus primary care. Differing perceptions/uses of discrete genomic data versus a PDF report. Classification and reclassification of variants. Conclusion Scaling the use of genomic data in the EHR requires the engagement of hospitals, open standards communities, laboratories, EHR vendors, and genomic information resources.
临床基因组数据在本地电子健康记录中的试点实施:可扩展性的挑战
摘要背景 最近,电子健康记录(EHR)供应商允许在EHR中存储离散的基因组数据。有了这种新能力,在采用和实施方面仍然存在许多挑战。盖辛格拥有大约145000名患者的基因组数据。为了将基因数据整合到整个测序人群的EHR中,我们对一个亚群进行了试点研究,以评估大规模部署的合理性。目的将七种药物基因、疾病控制中心一级疾病和遗传性血色素沉着症的遗传结果导入EHR。为每种情况建立决策支持和信息资源。确定扩展部署的障碍。确定克服已确定障碍的短期和长期解决方案。方法 离散的基因组变异被输入EHR。针对每种遗传状况制定了维护指南和信息资源,并针对药物基因组变异建立了最佳实践警报。每周举行电话会议,以解决执行方面的障碍。在整个过程中保留了一份挑战清单。提出了解决方案,并将其分为短期和长期解决方案。后果 确定了五个离散领域的挑战并提出了解决方案:将数据从实验室传输到EHR。维护信息和决策支持。遗传学家与初级保健的实施需求不同。与PDF报告相比,对离散基因组数据的不同看法/使用。变体的分类和重新分类。结论 扩大EHR中基因组数据的使用需要医院、开放标准社区、实验室、EHR供应商和基因组信息资源的参与。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书